From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak (Q83852253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

18

Muhamed-Kheir Taha

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

François Caron

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Isabelle Parent du Châtelet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jean-Philippe Leroy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Corinne Ruckly

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Myriam Blanchard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Nicole Bohic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Nathalie Massy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Isabelle Morer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Daniel Floret

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Valérie Delbos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Eva Hong

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Martin Révillion

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Gilles Berthelot

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ludovic Lemée

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ala-Eddine Deghmane

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jacques Bénichou

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Daniel Lévy-Bruhl

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

12 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

455-463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Meningococcal serotypes and serogroup B disease in north-west Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

An Epidemic Outbreak of Group B Meningococcal Disease on the Faroe Islands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Meningococcal protein antigens and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

A universal vaccine for serogroup B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine in Children Aged 16???24 Months

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

MeNZB vaccine and epidemic control: when do you stop vaccinating?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970027-5

7 January 2021

10.1016/S1473-3099(11)70027-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21489881%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference